POU3F3 ‐related disorder: Defining the phenotype and expanding the molecular spectrum
Clinical Genetics · 2023-08 · 104 (2) · 186-197
DOI: 10.1111/cge.14353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 10.05.2023. Verfasst von Alessandra Rossi und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark. Hauptthemen laut MEDLINE: Intellectual Disability, Autistic Disorder, Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, NINDS NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype–phenotype correlations in individuals with POU3F3‐related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA‐binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3‐related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype–phenotype correlations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
- Pediatric Clinic, IRCCS San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
- Human Genetics Department, Radboud University Medical Center, Nijmegen, the Netherlands.
- Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
- Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Centre Hospitalier Universitaire Dijon, Dijon, France.
- Genetics of Developmental Disorders Team, INSERM - Bourgogne Franche-Comté University, UMR 1231 GAD, Dijon, France.
ORCID-Profile: Konrad Platzer, Maria L Dentici, Marco Tartaglia, Marcello Niceta, Paolo Alfieri, Nicola Brunetti-Pierri, Deniz Torun, Mathilde F Lauridsen
Förderung
- Wellcome Trust
- NINDS NIH HHS
- NICHD NIH HHS
- Fondazione Telethon
- National Institute of Neurological Disorders and Stroke
- Novo Nordisk Fonden
Zitieren
APA
Rossi, A., Blok, L. S., Neuser, S., Klöckner, C., Platzer, K., Faivre, L. O., Weigand, H., Dentici, M. L., Tartaglia, M., Niceta, M., Alfieri, P., Srivastava, S., Coulter, D., Smith, L., Vinorum, K., Cappuccio, G., Brunetti-Pierri, N., Torun, D., Arslan, M., …, & Bayat, A. (2023). POU3F3 ‐related disorder: Defining the phenotype and expanding the molecular spectrum. Clinical Genetics, 104(2), 186-197. https://doi.org/10.1111/cge.14353
Vancouver
Rossi A, Blok LS, Neuser S, Klöckner C, Platzer K, Faivre LO, et al. POU3F3 ‐related disorder: Defining the phenotype and expanding the molecular spectrum. Clinical Genetics. 2023;104(2):186-197. doi:10.1111/cge.14353
BibTeX
@article{Rossi2023,
author = {Rossi, Alessandra and Blok, Lot Snijders and Neuser, Sonja and Klöckner, Chiara and Platzer, Konrad and Faivre, Laurence Olivier and Weigand, Heike and Dentici, Maria L and Tartaglia, Marco and Niceta, Marcello and Alfieri, Paolo and Srivastava, Siddharth and Coulter, David and Smith, Lacey and Vinorum, Kristin and Cappuccio, Gerarda and Brunetti-Pierri, Nicola and Torun, Deniz and Arslan, Mutluay and Lauridsen, Mathilde F and Murch, Oliver and Irving, Rachel and Lynch, Sally A and Mehta, Sarju G and Carmichael, Jenny and Zonneveld-Huijssoon, Evelien and de Vries, Bert and Kleefstra, Tjitske and Johannesen, Katrine M and Westphall, Ian T and Hughes, Susan S and Smithson, Sarah and Evans, Julie and Dudding-Byth, Tracy and Simon, Marleen and van Binsbergen, Ellen and Herkert, Johanna C and Beunders, Gea and Oppermann, Henry and Bakal, Mert and Møller, Rikke S and Rubboli, Guido and Bayat, Allan},
title = {POU3F3 ‐related disorder: Defining the phenotype and expanding the molecular spectrum},
journal = {Clinical Genetics},
year = {2023},
volume = {104},
number = {2},
pages = {186--197},
doi = {10.1111/cge.14353}
}
EUVIMED